Evaluation of Acute Kidney Injury in the Hospital Setting

Primary Care - Clinics in Office Practice

Volumn 41, Issue 4, 2014, Pages 779-802

  Eftekhari, Parham ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Acute kidney injury; Hospital acquired acute kidney injury; Hospital acquired acute renal failure; Nosocomial acute kidney injury; Nosocomial renal failure; Renal failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIGOUT AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BISPHOSPHONIC ACID DERIVATIVE; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; IODINATED CONTRAST MEDIUM; LITHIUM; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; BLOOD VESSEL INJURY; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION TEST; LABORATORY TEST; LIVER CIRRHOSIS; MEDICAL HISTORY; NEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; PEROPERATIVE COMPLICATION; PREVALENCE; PROPHYLAXIS; REVIEW; RISK FACTOR; SEPSIS; TREATMENT PLANNING; URINE VOLUME; ACUTE KIDNEY INJURY; ADVERSE DRUG REACTION; AGE; BLOOD EXAMINATION; COMORBIDITY; ECHOGRAPHY; ELECTROLYTE BALANCE; HEMODYNAMICS; PROGNOSIS; SEX DIFFERENCE; URINALYSIS;

ACUTE KIDNEY INJURY; AGE FACTORS; COMORBIDITY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEMATOLOGIC TESTS; HEMODYNAMICS; HOSPITALS; HUMANS; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX FACTORS; ULTRASONOGRAPHY; URINALYSIS; WATER-ELECTROLYTE BALANCE;

EID: 84909986505     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2014.08.005     Document Type: Review

References (83)

1. Bellomo R., Kellum J.A., Ronco C. Acute kidney injury. Lancet 2012, 380:756-766.
2. Thadhani R., Pascual M., Bonventre J.V. Acute renal failure. NEngl J Med 1996, 344:1448-1460.
3. Bellomo R., Kellum J.A., Ronco C., et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy, and information technology needs: the second international consensus of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2004, 8:R204-R212.
4. Hoste E., Schurgers M. Epidemiology of acute kidney injury: how big is the problem?. Crit Care Med 2008, 36(4):S146-S151.
5. Wang H.E., Muntner P., Chertow G.M., et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012, 35:349-355.
6. Chertow G.M., Burdick E., Honour M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. JAm Soc Nephrol 2005, 16:3365-3370.
7. Liangos O., Wald R., O'Bell J.W., et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006, 1:43-51.
8. Singbart K., Kellum J.A. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012, 81:819-825.
9. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10(3):R73.
10. Meran S., Wonnacott A., Amphlett B., et al. How good are we at managing acute kidney injury in hospital?. Clin Kidney J 2014, 7(2):144-150.
11. Case J., Khan S., Khalid R., et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013, 2013:479730.
12. Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systemic review. Kidney Int 2008, 73:538-546.
13. Uchino S., Bellomo R., Goldsmith D., et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care 2006, 34(7):1913-1917.
14. Matzke G.R., Aronoff G.R., Atinson A.J., et al. Drug dosing consideration in patients with acute and chronic kidney disease- a clinical update from Kidney disease: Improving Globe Outcomes (KDIGO). Kidney Int 2011, 80:1122-1137.
15. Hudson J.Q., Nyman H.A. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011, 20(5):482-491.
16. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992, 38:1933-1953.
17. Waikar S., Bonventre J.V. Creatinine kinetics and the definition of acute kidney injury. JAm Soc Nephrol 2009, 20(3):672-679.
18. Traynor J., Mactier R., Geddes C., et al. How to measure renal function in clinical practice. BMJ 2006, 333(7571):733-737.
19. Poggio E.D., Nef P.C., Wang X., et al. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis 2005, 46(2):242-252.
20. Bragadottir G., Redfors B., Ricksten S.E. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury- true GFR versus urinary creatinine clearance and estimating equations. Crit Care 2013, 17:R108.
21. Stevens L.A., Coresh J., Greene T., et al. Assessing kidney function- measured and estimated glomerular filtration rate. NEngl J Med 2006, 354:2473-2483.
22. Liano F., Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid acute renal failure study group. Kidney Int 1996, 50:811-818.
23. Nolan C., Anderson R. Hospital acquired acute renal failure. JAm Soc Nephrol 1998, 9:710-718.
24. Perazella M. Toxic nephropathies: core curriculum 2010. Am J Kidney Dis 2010, 55(2):399-409.
25. Nally J.V. Acute renal failure in hospitalized patients. Cleve Clin J Med 2002, 69(7):569-574.
26. Schetz M., Dasta J., Goldstein S., et al. Drug-induced acute kidney injury. Curr Opin Crit Care 2005, 11:555-565.
27. Guo X., Nzerue C. How to prevent, recognize, and treat drug-induced nephrotoxicity. Cleve Clin J Med 2002, 69(4):289-312.
28. Praga M., Gonzalez E. Acute interstitial nephritis. Kidney Int 2010, 77:956-961.
29. Perazella M.A. Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 2009, 4:1275-1283.
30. Lameire N. The pathophysiology of acute renal failure. Crit Care Clin 2005, 21:197-210.
31. Macedo E., Mehta R.L. Epidemiology, diagnosis, and therapy of acute kidney injury. Schrier's diseases of the kidney 2013, 785-825. Lippincott Williams & Wilkins, Philadelphia. 9th edition. T.M. Coffman, R.J. Falk, B.A. Molitoris (Eds.).
32. Tomlinson L.A., Abel G.A., Chaudhry A.N., et al. ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS One 2013, 8(11):e78465.
33. Schoolwerth A.C., Sica D.A., Ballermann B.J., et al. Renal consideration in angiotensin converting enzyme inhibitor therapy. Circulation 2001, 104:1985-1991.
34. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999, 106:13S-24S.
35. Perazella M.A., Tray K. Selective cyclooxygenase-2 inhibitors: a patter of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am J Med 2001, 111:64-71.
36. Palmer B. Nephrotoxicity of nonsteroidal anti-inflammatory agents, analgesics, and inhibitors of the rennin-angiotensin system. Schrier's diseases of the kidney 2013, 943-958. Lippincott Williams & Wilkins, Philadelphia. 9th edition. T.M. Coffman, R.J. Falk, B.A. Molitoris (Eds.).
37. Gines P., Schrier R.W. Renal failure in cirrhosis. NEngl J Med 2009, 361:1279-1290.
38. Wadei H.M., Mai M.L., Ahsan N., et al. Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol 2006, 1:1066-1079.
39. Ronco C., Haapio M., House A.A., et al. Cardiorenal syndrome. JAm Coll Cardiol 2008, 52:1527-1539.
40. Girman C.J., Kou T.D., Brodovicz K., et al. Risk of acute renal failure with type 2 diabetes mellitus. Diabet Med 2012, 29(5):614-621.
41. Barrett B.J. Contrast nephrotoxicity. JAm Soc Nephrol 1994, 5:125-137.
42. Rudnick M.R., Kesselheim A., Goldfarb S. Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med 2006, 73(1):75-87.
43. Eckardt K.U., Kasiske B., Kellum J.A., et al. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter 2012, 2(Suppl):1-138.
44. Deo A., Fogel M., Cowper S.E. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2007, 2(2):264-267.
45. Perazella M. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf 2008, 3:67-75.
46. Vanholder R., Sever M.S., Erek E., et al. Rhabdomyolysis. JAm Soc Nephrol 2000, 11(8):1553-1561.
47. Bosch X., Poch E., Grau J.M. Rhabdomyolysis and acute kidney injury. NEngl J Med 2009, 361:62-72.
48. Howard S.C., Jones D.P., Pui C.H. The tumor lysis syndrome. NEngl J Med 2011, 364:1844-1854.
49. Rossert J. Drug induced acute interstitial nephritis. Kidney Int 2001, 60:804-817.
50. Perazella M.A., Markowitz G.S. Drug induced acute interstitial nephritis. Nat Rev Nephrol 2010, 6:461-470.
51. Muriithi A.K., Nasr S.H., Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol 2013, 8(11):1857-1862.
52. Gonzales E., Gutierrez E., Galeano C., et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 2008, 73:940-946.
53. Hricik D., Chung-Park M., Sedor J.R. Glomerulonephritis. NEngl J Med 1998, 339:888-899.
54. Floege J., Feehally J. Introduction to glomerular disease: clinical presentations. Comprehensive clinical nephrology 2010, 193-207. WB Saunders, Philadelphia. 4th edition. J. Floege, R.J. Johnson, J. Feehally (Eds.).
55. Jennette J.C. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003, 63:1164-1177.
56. Nasr S.H., Radhakrishnan J., D'Agati V.D. Bacterial infection-related glomerulonephritis in adults. Kidney Int 2013, 83:792-803.
57. Scolari F., Ravani P. Atheroembolic renal disease. Lancet 2010, 375:1650-1660.
58. Ruggenenti P., Noris M., Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenia purpura. Kidney Int 2001, 60:831-846.
59. Moake J.L. Thrombotic microangiopathies. NEngl J Med 2002, 347:589-600.
60. George J.N. How I treat patients with thrombotic thrombocytopenia purpura: 2010. Blood 2010, 116(20):4060-4069.
61. Frokiaer J., Zeidel M. Urinary tract obstruction. Brenner and Rector's the kidney 2011, 1239-1264. Elsevier, NewYork. 9th edition. M.W. Taal, G.M. Chertow, P.A. Marsden (Eds.).
62. Curtis L.A., Dolan T.S., Cespedes R.D. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am 2001, 19(3):591-619.
63. Schrier R.W., Wang W., Poole B., et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. JClin Invest 2004, 114:5-14.
64. Yang L., Bonventre J.V. Diagnosis and clinical evaluation of acute kidney injury. Comprehensive clinical nephrology 2010, 821-829. WB Saunders, Philadelphia. 4th edition. J. Floege, R.J. Johnson, J. Feehally (Eds.).
65. United States Renal Data System (USRDS). Data report on acute kidney injury. Chapter 6. 2013. Available at: . Accessed on January 10, 2014. http://www.usrds.org/2013/view/v1_06.aspx.
66. Abdel-Kader K., Palevsky P. Acute kidney injury in the elderly. Clin Geriatr Med 2009, 25(3):331-358.
67. Chronopoulos A., Cruz D.N., Ronco C. Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol 2010, 6:141-149.
68. Zarjou A., Agarwal A. Sepsis and acute kidney injury. JAm Soc Nephrol 2011, 22(6):999-1006.
69. Ronco C., Kellum J.A., Bellomo R., et al. Potential interventions in sepsis related AKI. Clin J Am Soc Nephrol 2008, 3(2):531-544.
70. Thakar C.V., Christianson A., Himmelfarb J., et al. Chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 2011, 6(1):2567-2572.
71. Chawla L.S., Kimmel P.L. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012, 82:516-524.
72. Ishani A., Xue J.L., Himmelfarb J., et al. Acute kidney injury increases risk of ESRD among elderly. JAm Soc Nephrol 2009, 20:223-238.
73. Franceschini N., Napravnik S., Eron J.J., et al. Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int 2005, 67(4):1526-1531.
74. Wyatt C.M., Arons R.R., Klotman P.E., et al. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006, 20(4):561-565.
75. Thakar C.V. Perioperative acute kidney injury. Adv Chronic Kidney Dis 2013, 20(1):561-565.
76. Borthwick E., Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 2010, 341:85-91.
77. Liu Y.L., Prowle J., Licari E., et al. Changes in blood pressure before the development of nosocomial acute kidney injury. Nephrol Dial Transplant 2009, 24:504-511.
78. Mandelbaum T., Lee J., Scott D.J., et al. Empirical relationships among oliguria, creatinine, mortality, and renal replacement therapy in the critically ill. Intensive Care Med 2013, 39(3):414-419.
79. Oh H.J., Shin D.H., Lee M.J., et al. Urine output is associated with prognosis in patients with acute kidney injury requiring continuous renal replacement therapy. JCrit Care 2013, 28(4):379-388.
80. Inker L.A., Schmid C.H., Tighiouart H., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. NEngl J Med 2012, 367:20-29.
81. Zhang Z., Lu B., Sheng X., et al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2011, 58(3):356-365.
82. Rim M.Y., Ro H., Kang W.C., et al. The effect of rennin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity matched study. Am J Kidney Dis 2012, 60(4):576-582.
83. Pusey C.D., Levy J.B. Plasmapharesis in immunologic renal disease. Blood Purif 2012, 33(1-3):190-198.